Update on the CAPTIVATE trial of ibrutinib plus venetoclax
Clin Adv Hematol Oncol. 2023 Dec;21(12):654-657.NO ABSTRACTPMID:38039059
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Authors: Tanya Siddiqi Source Type: research
More News: Cancer & Oncology | Hematology